Selecta Biosciences has received a $3.2 million grant from the Skolkovo Foundation to develop an immunotherapy to treat cancers caused by the human papilloma virus

Research by scientists from the University of California, Los Angeles (UCLA) School of Dentistry could lead to a simple saliva test capable of diagnosing the

The risk of developing salivary gland cancer might be higher in people with mutations in either of two genes associated with breast and ovarian cancers,

Johns Hopkins researchers have developed blood and saliva tests that can accurately predict the recurrence of oropharyngeal squamous cell carcinoma (OPSCC) linked to human papillomavirus

Researchers at the Scripps Research Institute in Florida have made a clinical discovery that could help physicians develop new treatments for an oral cancer that

Mouse models of human oral cancer treated with capsazepine showed dramatic tumor shrinkage without damage to surrounding tissues, according to a new study in Oral

Missouri researchers have found a pattern of gene expression associated with aggressive tumors that could produce a diagnostic test that could alter the clinical management

U.S. researchers have developed a framework for exploiting the oral microbiome for monitoring oral cancer development, progression, and recurrence, according to a new article in

Doxepin rinse may prove to be an option to help relieve pain associated with oral mucositis in patients with head and neck cancers, according to

Cannabinoids may offer hope for oral cancer pain, according to a presentation at the recent American Pain Society (APS) annual meeting in Tampa, FL. A

Researchers from Finland have discovered a gene mutation in ameloblastoma, an odontogenic tumor with a high tendency to recur after treatment, as reported in the